Seagate (STX) stock rebounds toward $300 after Goldman target hike, earnings in focus

Seagate (STX) stock rebounds toward $300 after Goldman target hike, earnings in focus

Seagate Technology rose 5.4% to $299.92 after Goldman Sachs raised its price target to $310, citing strong 2026 pricing forecasts. The gain followed a 7.7% drop the previous day. A U.S. appeals court revived Seagate’s antitrust claims against NHK Spring late Thursday. Seagate’s next earnings report is expected around Jan. 20, though the date is unconfirmed.
Kohl’s stock slides 5% as tariff ruling delay hits retailers; KSS traders eye Jan. 14

Kohl’s stock slides 5% as tariff ruling delay hits retailers; KSS traders eye Jan. 14

Kohl’s shares fell 5.1% to $20.66 Friday afternoon, underperforming retail peers, after the Supreme Court delayed a decision on Trump-era tariffs. The broader market steadied following a softer jobs report, with nonfarm payrolls up 50,000 in December and unemployment at 4.4%. Investors remain uncertain about potential $150 billion in tariff refunds as the next court ruling is expected Jan. 14.
9 January 2026
Star Bulk Carriers (SBLK) stock drops nearly 5% as dry-bulk freight gauge slips

Star Bulk Carriers (SBLK) stock drops nearly 5% as dry-bulk freight gauge slips

Star Bulk Carriers shares dropped 4.8% to $19.76 by early afternoon Friday as the Baltic Dry Index slid to 1,688, down 31% in a month. The company last reported Q4 2025 TCE at $19,500 per day and paid a $0.11 dividend for Q3. Investors await the next results update on Feb. 25. Genco Shipping fell 3.7%, while Safe Bulkers and Diana Shipping edged higher.
Revolution Medicines stock rises as Merck buyout talks swirl; FDA designation adds another spark

Revolution Medicines stock rises as Merck buyout talks swirl; FDA designation adds another spark

Revolution Medicines shares rose 4.3% to $112.00 Friday after reports that Merck is in talks to buy the company for up to $32 billion. The FDA granted Breakthrough Therapy designation to Revolution’s KRAS-targeting lung cancer drug this week. AbbVie denied involvement in any deal. Revolution declined to comment on the takeover speculation.
Establishment Labs stock slides 5%: traders eye Motiva FDA next steps and JPM conference talk

Establishment Labs stock slides 5%: traders eye Motiva FDA next steps and JPM conference talk

Establishment Labs shares fell about 5% to $69.22 in early Friday trading, reversing part of a 10% gain earlier in the week. The drop came as broader U.S. markets rose on a softer December jobs report. Investors are watching for updates at the company’s Jan. 14 J.P. Morgan Healthcare Conference presentation and awaiting FDA review of its Motiva breast implants.
9 January 2026
Nvidia stock holds steady after China H200 pay-upfront report — what AI investors watch next

Nvidia stock holds steady after China H200 pay-upfront report — what AI investors watch next

Nvidia shares rose 0.1% to $185.31 Friday after Reuters reported the company now requires full upfront payment from Chinese buyers for H200 AI chips, with no cancellations or refunds allowed. Chinese tech firms have ordered over 2 million H200 chips, outstripping Nvidia’s inventory of about 700,000. Beijing has asked some firms to halt orders as it reviews conditions, even as U.S. export licenses are still pending.
9 January 2026
XRP price slips near $2 after Ripple’s UK FCA win — what traders watch next

XRP price slips near $2 after Ripple’s UK FCA win — what traders watch next

XRP dropped 1.9% to $2.09 Friday, while bitcoin and ether also slipped, as traders weighed Ripple’s UK approval for an electronic-money licence and cryptoasset registration. Coinbase fell 2.4% and Robinhood 0.4%. U.S. nonfarm payrolls rose 50,000 in December, missing forecasts. Investors await the Jan. 13 U.S. CPI report and the Federal Reserve’s Jan. 27-28 meeting.
SLV stock jumps as silver price nears $80 after softer U.S. jobs data

SLV stock jumps as silver price nears $80 after softer U.S. jobs data

iShares Silver Trust (SLV) surged 3.4% to $72.11 in New York Friday, tracking a 3.9% jump in spot silver after U.S. payrolls data missed forecasts and fueled bets on Fed rate cuts. Spot silver was on pace for a 10% weekly gain. Pan American Silver rose 1.8%, First Majestic Silver 4.3%. U.S. CPI data is due Jan. 13.
9 January 2026
Gold price stock rally: GLD, Newmont climb after soft U.S. jobs data lifts bullion

Gold price stock rally: GLD, Newmont climb after soft U.S. jobs data lifts bullion

Spot gold rose 0.6% to $4,502.98 an ounce Friday after U.S. payrolls data missed forecasts, pushing bullion near record highs. SPDR Gold Shares gained 0.3%, while Newmont, Agnico Eagle, and Franco-Nevada advanced. Investors await U.S. Supreme Court tariff rulings Jan. 14 and the Fed’s Jan. 27-28 meeting for further policy signals.
Vistra stock jumps as Meta locks in 20-year nuclear power deal for AI data centers

Vistra stock jumps as Meta locks in 20-year nuclear power deal for AI data centers

Vistra shares rose 11% to $167.11 by midday Friday after Meta signed 20-year nuclear power purchase agreements for 2,609 MW, with deliveries starting in late 2026. The deals cover Vistra’s Perry, Davis-Besse, and Beaver Valley plants. Investors focused on capital spending for upgrades and license extensions. Meta aims to secure power for its Ohio data center and future AI operations.
Qfin Holdings (QFIN) stock slides as China fintech ADRs lag on tariff limbo, credit jitters

Qfin Holdings (QFIN) stock slides as China fintech ADRs lag on tariff limbo, credit jitters

Qfin Holdings shares dropped 4.5% to $17.32 in Friday afternoon trading, hitting a session low of $17.21. FinVolution and LexinFintech also declined, as investors weighed U.S. tariff uncertainty and concerns over rising Chinese consumer loan defaults. China’s regulator recently extended a program for banks to offload bad loans. The broader U.S. market traded higher.
Why Soleno Therapeutics stock is down today: investor alerts revive Vykat XR scrutiny

Why Soleno Therapeutics stock is down today: investor alerts revive Vykat XR scrutiny

Soleno Therapeutics shares fell 5.6% to $42.95 Friday, underperforming the biotech sector after law firms announced “investigations” tied to past short-seller claims about Vykat XR. The company reported $66 million in quarterly revenue from the drug, approved for Prader-Willi syndrome, with 1,043 patient start forms since March. The stock hovered just above its 52-week low. Next update expected late February.
Bitcoin price wobbles near $90,000 as ETF outflows bite; Coinbase, Strategy stocks slide

Bitcoin price wobbles near $90,000 as ETF outflows bite; Coinbase, Strategy stocks slide

Bitcoin slipped 0.5% to about $90,700 Friday, while Coinbase fell 2% and Strategy nearly 5% in U.S. trading. Ether and XRP also declined. Investors pulled nearly $885 million from U.S. spot bitcoin ETFs over two days this week. Traders are watching U.S. inflation data due Jan. 13 and the Fed’s Jan. 27-28 meeting.
IREN stock rises as Bernstein calls it a “top AI pick” — what traders watch next

IREN stock rises as Bernstein calls it a “top AI pick” — what traders watch next

IREN shares rose 4.6% to $47.76 Friday, trading between $45.52 and $49.99 in heavy volume. Bernstein analyst Gautam Chhugani named IREN his top AI pick for 2026, according to TipRanks. Investors are watching for February earnings and signs of capital needs tied to the company’s AI expansion. IREN operates renewable-powered data centers in Canada and Texas and signed a $9.7 billion AI cloud deal with Microsoft last year.

Stock Market Today

Toyota stock price rises on CEO shake-up and higher profit outlook as buyout deadline nears

Toyota stock price rises on CEO shake-up and higher profit outlook as buyout deadline nears

7 February 2026
Toyota shares rose 2% to 3,780 yen Friday after the company raised its full-year profit forecast and announced CFO Kenta Kon will replace CEO Koji Sato on April 1. Third-quarter net revenues climbed 6.8% to 38.087 trillion yen, but North America posted a 5.6 billion yen operating loss. Toyota’s U.S. ADRs closed up 2.9%. The tender offer for Toyota Industries shares closes Feb. 12.
HSBC share price bounces back after BoE split vote — what to watch before Feb 25 results

HSBC share price bounces back after BoE split vote — what to watch before Feb 25 results

7 February 2026
HSBC shares closed up 2.2% at £13.06 on Friday, reversing Thursday’s drop as traders weighed possible Bank of England rate cuts and awaited the bank’s annual results on Feb. 25. The FTSE 100 rose 0.6%, with major UK banks also gaining. HSBC is also preparing to cut some banker bonuses and push out underperformers amid a cost reset. Key UK, U.S., and euro zone economic data are due next week.
Go toTop